2018 MEDICARE LOCAL COVERAGE DETERMINATION (LCD) - L34313 CPT CODES: 86003, ALLERGY TESTING

Transcription

1 H Chronic giant papillary conjunctivitis, right eye H Chronic giant papillary conjunctivitis, left eye H Chronic giant papillary conjunctivitis, bilateral H10.45 Other chronic allergic conjunctivitis H Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), right ear H Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), left ear H Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), bilateral Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), recurrent, right H ear Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), recurrent, left H ear Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), recurrent, H bilateral H Other acute nonsuppurative otitis media, recurrent, right ear H Other acute nonsuppurative otitis media, recurrent, left ear H Other acute nonsuppurative otitis media, recurrent, bilateral H65.21 Chronic serous otitis media, right ear H65.22 Chronic serous otitis media, left ear H65.23 Chronic serous otitis media, bilateral H Chronic allergic otitis media, right ear H Chronic allergic otitis media, left ear H Chronic allergic otitis media, bilateral H Other chronic nonsuppurative otitis media, right ear H Other chronic nonsuppurative otitis media, left ear H Other chronic nonsuppurative otitis media, bilateral H Chronic Eustachian salpingitis, right ear H Chronic Eustachian salpingitis, left ear H Chronic Eustachian salpingitis, bilateral H69.81 Other specified disorders of Eustachian tube, right ear H69.82 Other specified disorders of Eustachian tube, left ear H69.83 Other specified disorders of Eustachian tube, bilateral J20.8 Acute bronchitis due to other specified organisms J30.0 Vasomotor rhinitis J30.1 Allergic rhinitis due to pollen J30.2 Other seasonal allergic rhinitis J30.5 Allergic rhinitis due to food 1 of 13

2 J30.81 Allergic rhinitis due to animal (cat) (dog) hair and dander J30.89 Other allergic rhinitis J31.0 Chronic rhinitis J33.0 Polyp of nasal cavity J33.1 Polypoid sinus degeneration J33.8 Other polyp of sinus J33.9 Nasal polyp, unspecified J34.1 Cyst and mucocele of nose and nasal sinus J34.81 Nasal mucositis (ulcerative) J35.01 Chronic tonsillitis J35.02 Chronic adenoiditis J35.03 Chronic tonsillitis and adenoiditis J35.1 Hypertrophy of tonsils J35.2 Hypertrophy of adenoids J35.3 Hypertrophy of tonsils with hypertrophy of adenoids J45.20 Mild intermittent asthma, uncomplicated J45.21 Mild intermittent asthma with (acute) exacerbation J45.22 Mild intermittent asthma with status asthmaticus J45.30 Mild persistent asthma, uncomplicated J45.31 Mild persistent asthma with (acute) exacerbation J45.32 Mild persistent asthma with status asthmaticus J45.40 Moderate persistent asthma, uncomplicated J45.41 Moderate persistent asthma with (acute) exacerbation J45.42 Moderate persistent asthma with status asthmaticus J45.50 Severe persistent asthma, uncomplicated J45.51 Severe persistent asthma with (acute) exacerbation J45.52 Severe persistent asthma with status asthmaticus J Unspecified asthma with (acute) exacerbation J Unspecified asthma with status asthmaticus J Unspecified asthma, uncomplicated J Cough variant asthma J Other asthma L20.0 Besnier's prurigo L20.81 Atopic neurodermatitis L20.82 Flexural eczema L20.83 Infantile (acute) (chronic) eczema L20.84 Intrinsic (allergic) eczema 2 of 13

3 L20.89 Other atopic dermatitis L20.9 Atopic dermatitis, unspecified L27.0 Generalized skin eruption due to drugs and medicaments taken internally L27.1 Localized skin eruption due to drugs and medicaments taken internally L27.2 Dermatitis due to ingested food L27.8 Dermatitis due to other substances taken internally L27.9 Dermatitis due to unspecified substance taken internally L30.0 Nummular dermatitis L30.2 Cutaneous autosensitization L30.8 Other specified dermatitis L50.0 Allergic urticaria L50.1 Idiopathic urticaria L50.6 Contact urticaria L50.8 Other urticaria L50.9 Urticaria, unspecified R05 Cough R06.00 Dyspnea, unspecified R06.02 Shortness of breath R06.09 Other forms of dyspnea R06.2 Wheezing R06.9 Unspecified abnormalities of breathing R09.81 Nasal congestion R21 Rash and other nonspecific skin eruption R43.0 Anosmia R43.1 Parosmia R43.2 Parageusia R43.8 Other disturbances of smell and taste R43.9 Unspecified disturbances of smell and taste T36.0X5A Adverse effect of penicillins, initial T36.0X5S Adverse effect of penicillins, sequela T36.1X5A T36.1X5S T36.2X5A T36.2X5S T36.3X5A T36.3X5S Adverse effect of cephalosporins and other beta-lactam antibiotics, initial Adverse effect of cephalosporins and other beta-lactam antibiotics, sequela Adverse effect of chloramphenicol group, initial Adverse effect of chloramphenicol group, sequela Adverse effect of macrolides, initial Adverse effect of macrolides, sequela 3 of 13

4 T36.4X5A T36.4X5S T36.5X5A T36.5X5S T36.6X5A T36.6X5S T36.7X5A T36.7X5S T36.8X5A T36.8X5S T37.0X5A T37.0X5S T37.1X5A T37.1X5S T37.2X5A Adverse effect of tetracyclines, initial Adverse effect of tetracyclines, sequela Adverse effect of aminoglycosides, initial Adverse effect of aminoglycosides, sequela Adverse effect of rifampicins, initial Adverse effect of rifampicins, sequela Adverse effect of antifungal antibiotics, systemically used, initial Adverse effect of antifungal antibiotics, systemically used, sequela Adverse effect of other systemic antibiotics, initial Adverse effect of other systemic antibiotics, sequela Adverse effect of sulfonamides, initial Adverse effect of sulfonamides, sequela Adverse effect of antimycobacterial drugs, initial Adverse effect of antimycobacterial drugs, sequela Adverse effect of antimalarials and drugs acting on other blood protozoa, initial T37.2X5S T37.3X5A T37.3X5S T37.4X5A T37.4X5S T37.5X5A T38.0X5A T38.0X5S T38.1X5A T38.1X5S T38.2X5A T38.2X5S T38.3X5A T38.3X5S T38.4X5A T38.4X5S T38.5X5A T38.5X5S Adverse effect of antimalarials and drugs acting on other blood protozoa, sequela Adverse effect of other antiprotozoal drugs, initial Adverse effect of other antiprotozoal drugs, sequela Adverse effect of anthelminthics, initial Adverse effect of anthelminthics, sequela Adverse effect of antiviral drugs, initial Adverse effect of glucocorticoids and synthetic analogues, initial Adverse effect of glucocorticoids and synthetic analogues, sequela Adverse effect of thyroid hormones and substitutes, initial Adverse effect of thyroid hormones and substitutes, sequela Adverse effect of antithyroid drugs, initial Adverse effect of antithyroid drugs, sequela Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, sequela Adverse effect of oral contraceptives, initial Adverse effect of oral contraceptives, sequela Adverse effect of other estrogens and progestogens, initial Adverse effect of other estrogens and progestogens, sequela 4 of 13

5 T38.6X5A T38.6X5S T38.7X5A T38.7X5S T38.815A T38.815S T38.895A T38.895S T38.995A T38.995S T39.015A T39.015S T39.095A T39.095S T39.1X5A T39.1X5S T39.2X5A T39.2X5S T39.315A T39.315S T39.395A T39.395S T39.4X5A T39.4X5S T39.8X5A T39.8X5S T40.0X5A T40.0X5S T40.2X5A T40.2X5S Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela Adverse effect of androgens and anabolic congeners, initial Adverse effect of androgens and anabolic congeners, sequela Adverse effect of anterior pituitary [adenohypophyseal] hormones, initial Adverse effect of anterior pituitary [adenohypophyseal] hormones, sequela Adverse effect of other hormones and synthetic substitutes, initial Adverse effect of other hormones and synthetic substitutes, sequela Adverse effect of other hormone antagonists, initial Adverse effect of other hormone antagonists, sequela Adverse effect of aspirin, initial Adverse effect of aspirin, sequela Adverse effect of salicylates, initial Adverse effect of salicylates, sequela Adverse effect of 4-Aminophenol derivatives, initial Adverse effect of 4-Aminophenol derivatives, sequela Adverse effect of pyrazolone derivatives, initial Adverse effect of pyrazolone derivatives, sequela Adverse effect of propionic acid derivatives, initial Adverse effect of propionic acid derivatives, sequela Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela Adverse effect of antirheumatics, not elsewhere classified, initial Adverse effect of antirheumatics, not elsewhere classified, sequela Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela Adverse effect of opium, initial Adverse effect of opium, sequela Adverse effect of other opioids, initial Adverse effect of other opioids, sequela 5 of 13

6 T40.3X5A T40.3X5S T40.4X5A T40.4X5S T40.5X5A T40.5X5S T40.695A T40.695S T40.7X5A T40.7X5S T40.995A T40.995S T41.0X5A T41.0X5S T41.1X5A T41.1X5S T41.295A T41.295S T41.3X5A T41.3X5S T41.5X5A T41.5X5S T42.0X5A T42.0X5S T42.1X5A T42.1X5S T42.2X5A T42.2X5S T42.3X5A T42.4X5A T42.4X5S T42.5X5A T42.5X5S T42.6X5A T42.6X5S Adverse effect of methadone, initial Adverse effect of methadone, sequela Adverse effect of other synthetic narcotics, initial Adverse effect of other synthetic narcotics, sequela Adverse effect of cocaine, initial Adverse effect of cocaine, sequela Adverse effect of other narcotics, initial Adverse effect of other narcotics, sequela Adverse effect of cannabis (derivatives), initial Adverse effect of cannabis (derivatives), sequela Adverse effect of other psychodysleptics [hallucinogens], initial Adverse effect of other psychodysleptics [hallucinogens], sequela Adverse effect of inhaled anesthetics, initial Adverse effect of inhaled anesthetics, sequela Adverse effect of intravenous anesthetics, initial Adverse effect of intravenous anesthetics, sequela Adverse effect of other general anesthetics, initial Adverse effect of other general anesthetics, sequela Adverse effect of local anesthetics, initial Adverse effect of local anesthetics, sequela Adverse effect of therapeutic gases, initial Adverse effect of therapeutic gases, sequela Adverse effect of hydantoin derivatives, initial Adverse effect of hydantoin derivatives, sequela Adverse effect of iminostilbenes, initial Adverse effect of iminostilbenes, sequela Adverse effect of succinimides and oxazolidinediones, initial Adverse effect of succinimides and oxazolidinediones, sequela Adverse effect of barbiturates, initial Adverse effect of benzodiazepines, initial Adverse effect of benzodiazepines, sequela Adverse effect of mixed antiepileptics, initial Adverse effect of mixed antiepileptics, sequela Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial Adverse effect of other antiepileptic and sedative-hypnotic drugs, sequela 6 of 13

7 T42.8X5A T42.8X5S T43.015A T43.015S T43.025A T43.025S T43.1X5A T43.1X5S T43.215A T43.215S T43.225A T43.225S T43.295A T43.295S T43.3X5A T43.3X5S T43.4X5A T43.4X5S T43.595A T43.595S T43.615A T43.615S T43.625A T43.625S T43.635A T43.635S T43.695A T43.695S T43.8X5A T43.8X5S Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela Adverse effect of tricyclic antidepressants, initial Adverse effect of tricyclic antidepressants, sequela Adverse effect of tetracyclic antidepressants, initial Adverse effect of tetracyclic antidepressants, sequela Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial Adverse effect of monoamine-oxidase-inhibitor antidepressants, sequela Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela Adverse effect of selective serotonin reuptake inhibitors, initial Adverse effect of selective serotonin reuptake inhibitors, sequela Adverse effect of other antidepressants, initial Adverse effect of other antidepressants, sequela Adverse effect of phenothiazine antipsychotics and neuroleptics, initial Adverse effect of phenothiazine antipsychotics and neuroleptics, sequela Adverse effect of butyrophenone and thiothixene neuroleptics, initial Adverse effect of butyrophenone and thiothixene neuroleptics, sequela Adverse effect of other antipsychotics and neuroleptics, initial Adverse effect of other antipsychotics and neuroleptics, sequela Adverse effect of caffeine, initial Adverse effect of caffeine, sequela Adverse effect of amphetamines, initial Adverse effect of amphetamines, sequela Adverse effect of methylphenidate, initial Adverse effect of methylphenidate, sequela Adverse effect of other psychostimulants, initial Adverse effect of other psychostimulants, sequela Adverse effect of other psychotropic drugs, initial Adverse effect of other psychotropic drugs, sequela 7 of 13

8 T44.0X5A T44.0X5S T44.1X5A T44.1X5S T44.2X5A T44.2X5S T44.3X5A T44.3X5S T44.4X5A T44.4X5S T44.5X5A T44.5X5S T44.6X5A T44.6X5S T44.7X5A T44.7X5S T44.8X5A T44.8X5S T44.995A T44.995S T45.0X5A T45.0X5S T45.1X5A T45.1X5S T45.2X5A T45.2X5S T45.3X5A T45.3X5S Adverse effect of anticholinesterase agents, initial Adverse effect of anticholinesterase agents, sequela Adverse effect of other parasympathomimetics [cholinergics], initial Adverse effect of other parasympathomimetics [cholinergics], sequela Adverse effect of ganglionic blocking drugs, initial Adverse effect of ganglionic blocking drugs, sequela Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela Adverse effect of predominantly alpha-adrenoreceptor agonists, initial Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela Adverse effect of predominantly beta-adrenoreceptor agonists, initial Adverse effect of predominantly beta-adrenoreceptor agonists, sequela Adverse effect of alpha-adrenoreceptor antagonists, initial Adverse effect of alpha-adrenoreceptor antagonists, sequela Adverse effect of beta-adrenoreceptor antagonists, initial Adverse effect of beta-adrenoreceptor antagonists, sequela Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela Adverse effect of other drug primarily affecting the autonomic nervous system, initial Adverse effect of other drug primarily affecting the autonomic nervous system, sequela Adverse effect of antiallergic and antiemetic drugs, initial Adverse effect of antiallergic and antiemetic drugs, sequela Adverse effect of antineoplastic and immunosuppressive drugs, initial Adverse effect of antineoplastic and immunosuppressive drugs, sequela Adverse effect of vitamins, initial Adverse effect of vitamins, sequela Adverse effect of enzymes, initial Adverse effect of enzymes, sequela 8 of 13

9 T45.4X5A T45.4X5S T45.515A T45.515S T45.525A T45.525S T45.615A T45.615S T45.625A T45.625S T45.695A T45.695S T45.7X5A Adverse effect of iron and its compounds, initial Adverse effect of iron and its compounds, sequela Adverse effect of anticoagulants, initial Adverse effect of anticoagulants, sequela Adverse effect of antithrombotic drugs, initial Adverse effect of antithrombotic drugs, sequela Adverse effect of thrombolytic drugs, initial Adverse effect of thrombolytic drugs, sequela Adverse effect of hemostatic drug, initial Adverse effect of hemostatic drug, sequela Adverse effect of other fibrinolysis-affecting drugs, initial Adverse effect of other fibrinolysis-affecting drugs, sequela Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial T45.7X5S T45.8X5A T45.8X5S T46.0X5A T46.0X5S T46.1X5A T46.1X5S T46.2X5A T46.2X5S T46.3X5A T46.3X5S T46.4X5A T46.4X5S T46.5X5A T46.5X5S T46.6X5A T46.6X5S T46.7X5A Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela Adverse effect of other primarily systemic and hematological agents, initial Adverse effect of other primarily systemic and hematological agents, sequela Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela Adverse effect of calcium-channel blockers, initial Adverse effect of calcium-channel blockers, sequela Adverse effect of other antidysrhythmic drugs, initial Adverse effect of other antidysrhythmic drugs, sequela Adverse effect of coronary vasodilators, initial Adverse effect of coronary vasodilators, sequela Adverse effect of angiotensin-converting-enzyme inhibitors, initial Adverse effect of angiotensin-converting-enzyme inhibitors, sequela Adverse effect of other antihypertensive drugs, initial Adverse effect of other antihypertensive drugs, sequela Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela Adverse effect of peripheral vasodilators, initial 9 of 13

10 T46.7X5S T46.8X5A T46.8X5S T46.995A T46.995S T47.0X5A T47.0X5S T47.1X5A T47.1X5S T47.2X5A T47.2X5S T47.3X5A T47.3X5S T47.4X5A T47.4X5S T47.5X5A T47.5X5S T47.6X5A T47.6X5S T47.7X5A T47.7X5S T47.8X5A T47.8X5S T48.0X5A T48.0X5S T48.1X5A T48.1X5S T48.295A T48.295S Adverse effect of peripheral vasodilators, sequela Adverse effect of antivaricose drugs, including sclerosing agents, initial Adverse effect of antivaricose drugs, including sclerosing agents, sequela Adverse effect of other agents primarily affecting the cardiovascular system, initial Adverse effect of other agents primarily affecting the cardiovascular system, sequela Adverse effect of histamine H2-receptor blockers, initial Adverse effect of histamine H2-receptor blockers, sequela Adverse effect of other antacids and anti-gastric-secretion drugs, initial Adverse effect of other antacids and anti-gastric-secretion drugs, sequela Adverse effect of stimulant laxatives, initial Adverse effect of stimulant laxatives, sequela Adverse effect of saline and osmotic laxatives, initial Adverse effect of saline and osmotic laxatives, sequela Adverse effect of other laxatives, initial Adverse effect of other laxatives, sequela Adverse effect of digestants, initial Adverse effect of digestants, sequela Adverse effect of antidiarrheal drugs, initial Adverse effect of antidiarrheal drugs, sequela Adverse effect of emetics, initial Adverse effect of emetics, sequela Adverse effect of other agents primarily affecting gastrointestinal system, initial Adverse effect of other agents primarily affecting gastrointestinal system, sequela Adverse effect of oxytocic drugs, initial Adverse effect of oxytocic drugs, sequela Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela Adverse effect of other drugs acting on muscles, initial Adverse effect of other drugs acting on muscles, sequela 10 of 13

11 T48.3X5A T48.3X5S T48.4X5A T48.4X5S T48.5X5A T48.5X5S T48.6X5A T48.6X5S T48.995A Adverse effect of antitussives, initial Adverse effect of antitussives, sequela Adverse effect of expectorants, initial Adverse effect of expectorants, sequela Adverse effect of other anti-common-cold drugs, initial Adverse effect of other anti-common-cold drugs, sequela Adverse effect of antiasthmatics, initial Adverse effect of antiasthmatics, sequela Adverse effect of other agents primarily acting on the respiratory system, initial T48.995S T49.0X5A T49.0X5S T49.1X5A T49.1X5S T49.2X5A T49.2X5S T49.3X5A T49.3X5S T49.4X5A T49.4X5S T49.5X5A T49.5X5S T49.6X5A T49.6X5S T49.7X5A T49.7X5S T49.8X5A T49.8X5S T50.0X5A T50.0X5S Adverse effect of other agents primarily acting on the respiratory system, sequela Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela Adverse effect of antipruritics, initial Adverse effect of antipruritics, sequela Adverse effect of local astringents and local detergents, initial Adverse effect of local astringents and local detergents, sequela Adverse effect of emollients, demulcents and protectants, initial Adverse effect of emollients, demulcents and protectants, sequela Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela Adverse effect of ophthalmological drugs and preparations, initial Adverse effect of ophthalmological drugs and preparations, sequela Adverse effect of otorhinolaryngological drugs and preparations, initial Adverse effect of otorhinolaryngological drugs and preparations, sequela Adverse effect of dental drugs, topically applied, initial Adverse effect of dental drugs, topically applied, sequela Adverse effect of other topical agents, initial Adverse effect of other topical agents, sequela Adverse effect of mineralocorticoids and their antagonists, initial Adverse effect of mineralocorticoids and their antagonists, sequela 11 of 13

12 T50.1X5A T50.1X5S T50.2X5A T50.2X5S Adverse effect of loop [high-ceiling] diuretics, initial Adverse effect of loop [high-ceiling] diuretics, sequela Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela T50.3X5A T50.3X5S T50.4X5A T50.4X5S T50.5X5A T50.5X5S T50.6X5A T50.6X5S T50.7X5A T50.7X5S T50.8X5A T50.8X5S T50.A15A T50.A15S T50.A25A T50.A25S T50.A95A T50.A95S T50.B15A T50.B15S T50.B95A T50.B95S T50.Z15A T50.Z15S T50.Z95A Adverse effect of electrolytic, caloric and water-balance agents, initial Adverse effect of electrolytic, caloric and water-balance agents, sequela Adverse effect of drugs affecting uric acid metabolism, initial Adverse effect of drugs affecting uric acid metabolism, sequela Adverse effect of appetite depressants, initial Adverse effect of appetite depressants, sequela Adverse effect of antidotes and chelating agents, initial Adverse effect of antidotes and chelating agents, sequela Adverse effect of analeptics and opioid receptor antagonists, initial Adverse effect of analeptics and opioid receptor antagonists, sequela Adverse effect of diagnostic agents, initial Adverse effect of diagnostic agents, sequela Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial Adverse effect of pertussis vaccine, including combinations with a pertussis component, sequela Adverse effect of mixed bacterial vaccines without a pertussis component, initial Adverse effect of mixed bacterial vaccines without a pertussis component, sequela Adverse effect of other bacterial vaccines, initial Adverse effect of other bacterial vaccines, sequela Adverse effect of smallpox vaccines, initial Adverse effect of smallpox vaccines, sequela Adverse effect of other viral vaccines, initial Adverse effect of other viral vaccines, sequela Adverse effect of immunoglobulin, initial Adverse effect of immunoglobulin, sequela Adverse effect of other vaccines and biological substances, initial 12 of 13

13 T50.Z95S T50.995A T50.995S Adverse effect of other vaccines and biological substances, sequela Adverse effect of other drugs, medicaments and biological substances, initial Adverse effect of other drugs, medicaments and biological substances, sequela 13 of 13